Nontuberculous mycobacteria (NTM) have recently emerged as important pathogens among
cystic fibrosis (CF) patients worldwide. Mycobacterium abscessus is becoming the most …

Mycobacterium abscessus is a nontuberculosis mycobacterium (NTM) that has shown an
exponential rise in its ability to cause disease. Due to its ubiquitous presence in the …

Mycobacterium abscessus is a member of the non-tuberculous mycobacteria (NTM) group,
responsible for chronic infections in individuals with cystic fibrosis (CF) or those otherwise …

Persistence of infection despite extensive chemotherapy with antibiotics displaying low MICs
is a hallmark of lung disease caused by Mycobacterium abscessus (Mab). Thus, the …

Biofilm formation is an important factor for Mycobacterium abscessus to resist harsh
environment and produce drug resistance. The anti-biofilm activity of a newly designed …

Mycobacterium abscessus biofilm aggregates have been shown in the lungs of cystic
fibrosis patients and are often tolerant to drugs. Herein, we analyzed bi-dimensional images …

Antibiotic tolerance—the ability of bacteria to survive for an extended time in the presence of
bactericidal antibiotics—is an understudied contributor to antibiotic treatment failure. Herein …

Mycobacterium abscessus is a non-tuberculous mycobacterium notoriously known for
causing severe, chronic infections. Treatment of these infections is challenging due to either …

Mycobacterium abscessus is an emerging opportunistic pathogen responsible for chronic
lung diseases, especially in patients with cystic fibrosis. Treatment failure of M. abscessus …

Mycobacterium abscessus is the one of the most feared bacterial respiratory pathogens in
the world. Unfortunately, there are many problems with the current M. abscessus therapies …